ID   ODPX_HUMAN              Reviewed;         501 AA.
AC   O00330; B4DW62; D3DR11; E9PB14; E9PBP7; O60221; Q96FV8; Q99783;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2001, sequence version 3.
DT   10-MAY-2017, entry version 174.
DE   RecName: Full=Pyruvate dehydrogenase protein X component, mitochondrial;
DE   AltName: Full=Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex;
DE   AltName: Full=E3-binding protein;
DE            Short=E3BP;
DE   AltName: Full=Lipoyl-containing pyruvate dehydrogenase complex component X;
DE   AltName: Full=proX;
DE   Flags: Precursor;
GN   Name=PDHX; Synonyms=PDX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT CYS-23.
RX   PubMed=9242632; DOI=10.1074/jbc.272.32.19746;
RA   Harris R.A., Bowker-Kinley M.M., Wu P., Jeng J., Popov K.M.;
RT   "Dihydrolipoamide dehydrogenase-binding protein of the human pyruvate
RT   dehydrogenase complex. DNA-derived amino acid sequence, expression,
RT   and reconstitution of the pyruvate dehydrogenase complex.";
RL   J. Biol. Chem. 272:19746-19751(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INVOLVEMENT IN PDHXD.
RC   TISSUE=Liver;
RX   PubMed=9399911; DOI=10.1086/301653;
RA   Aral B., Benelli C., Ait-Ghezala G., Amessou M., Fouque F.,
RA   Maunoury C., Creau N., Kamoun P., Marsac C.;
RT   "Mutations in PDX1, the human lipoyl-containing component X of the
RT   pyruvate dehydrogenase-complex gene on chromosome 11p1, in congenital
RT   lactic acidosis.";
RL   Am. J. Hum. Genet. 61:1318-1326(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9467010; DOI=10.1093/hmg/7.3.501;
RA   Ling M., McEachern G., Seyda A., Mackay N., Scherer S.W.,
RA   Bratinova S., Beatty B., Giovannucci-Uzielli M.L., Robinson B.H.;
RT   "Detection of a homozygous four base pair deletion in the protein X
RT   gene in a case of pyruvate dehydrogenase complex deficiency.";
RL   Hum. Mol. Genet. 7:501-505(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Aral B., Dey R., Marsac C.;
RT   "Human gene sequence for PDX1, the human lipoyl-containing component X
RT   of the pyruvate dehydrogenase complex.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-370.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 127-501 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9110174;
RA   Yu W., Andersson B., Worley K.C., Muzny D.M., Ding Y., Liu W.,
RA   Ricafrente J.Y., Wentland M.A., Lennon G., Gibbs R.A.;
RT   "Large-scale concatenation cDNA sequencing.";
RL   Genome Res. 7:353-358(1997).
RN   [10]
RP   SUBUNIT.
RX   PubMed=14638692; DOI=10.1074/jbc.M308172200;
RA   Hiromasa Y., Fujisawa T., Aso Y., Roche T.E.;
RT   "Organization of the cores of the mammalian pyruvate dehydrogenase
RT   complex formed by E2 and E2 plus the E3-binding protein and their
RT   capacities to bind the E1 and E3 components.";
RL   J. Biol. Chem. 279:6921-6933(2004).
RN   [11]
RP   INTERACTION WITH DLD, AND MUTAGENESIS OF ASN-190; ARG-208 AND ILE-210.
RX   PubMed=20160912; DOI=10.1016/j.molcatb.2009.05.001;
RA   Patel M.S., Korotchkina L.G., Sidhu S.;
RT   "Interaction of E1 and E3 components with the core proteins of the
RT   human pyruvate dehydrogenase complex.";
RL   J. Mol. Catal., B Enzym. 61:2-6(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-194, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   INTERACTION WITH DLD.
RX   PubMed=20385101; DOI=10.1016/j.bbrc.2010.04.038;
RA   Park Y.H., Patel M.S.;
RT   "Characterization of interactions of dihydrolipoamide dehydrogenase
RT   with its binding protein in the human pyruvate dehydrogenase
RT   complex.";
RL   Biochem. Biophys. Res. Commun. 395:416-419(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   INTERACTION WITH SIRT4, LIPOYLATION AT LYS-97, AND DELIPOYLATION AT
RP   LYS-97.
RX   PubMed=25525879; DOI=10.1016/j.cell.2014.11.046;
RA   Mathias R.A., Greco T.M., Oberstein A., Budayeva H.G., Chakrabarti R.,
RA   Rowland E.A., Kang Y., Shenk T., Cristea I.M.;
RT   "Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex
RT   activity.";
RL   Cell 159:1615-1625(2014).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-196, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.59 ANGSTROMS) OF 54-274 IN COMPLEX WITH DLD.
RX   PubMed=16263718; DOI=10.1074/jbc.M507850200;
RA   Ciszak E.M., Makal A., Hong Y.S., Vettaikkorumakankauv A.K.,
RA   Korotchkina L.G., Patel M.S.;
RT   "How dihydrolipoamide dehydrogenase-binding protein binds
RT   dihydrolipoamide dehydrogenase in the human pyruvate dehydrogenase
RT   complex.";
RL   J. Biol. Chem. 281:648-655(2006).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 174-230 IN COMPLEX WITH DLD,
RP   AND MUTAGENESIS OF ARG-183; SER-185; PRO-186; ALA-187; ARG-189;
RP   ASN-190; GLU-193; ARG-208; ILE-210; LYS-213 AND GLU-214.
RX   PubMed=16442803; DOI=10.1016/j.str.2006.01.001;
RA   Brautigam C.A., Wynn R.M., Chuang J.L., Machius M., Tomchick D.R.,
RA   Chuang D.T.;
RT   "Structural insight into interactions between dihydrolipoamide
RT   dehydrogenase (E3) and E3 binding protein of human pyruvate
RT   dehydrogenase complex.";
RL   Structure 14:611-621(2006).
RN   [20]
RP   STRUCTURE BY NMR OF 57-141.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of RSGI RUH-054, a lipoyl domain from human 2-
RT   oxoacid dehydrogenase.";
RL   Submitted (OCT-2006) to the PDB data bank.
RN   [21]
RP   CRYO-ELECTRON MICROSCOPY (18.3 ANGSTROMS) OF INNER CORE OF THE
RP   COMPLEX, AND SUBUNIT.
RX   PubMed=20361979; DOI=10.1016/j.jmb.2010.03.043;
RA   Vijayakrishnan S., Kelly S.M., Gilbert R.J., Callow P., Bhella D.,
RA   Forsyth T., Lindsay J.G., Byron O.;
RT   "Solution structure and characterisation of the human pyruvate
RT   dehydrogenase complex core assembly.";
RL   J. Mol. Biol. 399:71-93(2010).
CC   -!- FUNCTION: Required for anchoring dihydrolipoamide dehydrogenase
CC       (E3) to the dihydrolipoamide transacetylase (E2) core of the
CC       pyruvate dehydrogenase complexes of eukaryotes. This specific
CC       binding is essential for a functional PDH complex.
CC   -!- SUBUNIT: Part of the inner core of the multimeric pyruvate
CC       dehydrogenase complex that is composed of about 48 DLAT and 12
CC       PDHX molecules (PubMed:14638692, PubMed:20361979). This core binds
CC       multiple copies of pyruvate dehydrogenase (subunits PDH1A and
CC       PDHB, E1), dihydrolipoamide acetyltransferase (DLAT, E2) and
CC       lipoamide dehydrogenase (DLD, E3) (PubMed:14638692). Interacts
CC       with SIRT4 (PubMed:25525879). Interacts with DLD (PubMed:20385101,
CC       PubMed:16263718, PubMed:16442803, PubMed:20160912,
CC       PubMed:20361979). {ECO:0000269|PubMed:14638692,
CC       ECO:0000269|PubMed:16263718, ECO:0000269|PubMed:16442803,
CC       ECO:0000269|PubMed:20160912, ECO:0000269|PubMed:20361979,
CC       ECO:0000269|PubMed:20385101, ECO:0000269|PubMed:25525879}.
CC   -!- INTERACTION:
CC       Q6RW13:AGTRAP; NbExp=4; IntAct=EBI-751566, EBI-741181;
CC       Q9Y6E7:SIRT4; NbExp=4; IntAct=EBI-751566, EBI-2606540;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O00330-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00330-2; Sequence=VSP_045271;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O00330-3; Sequence=VSP_053817;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- PTM: Delipoylated at Lys-97 by SIRT4, delipoylation decreases the
CC       PHD complex activity. {ECO:0000269|PubMed:25525879}.
CC   -!- DISEASE: Pyruvate dehydrogenase E3-binding protein deficiency
CC       (PDHXD) [MIM:245349]: A metabolic disorder characterized by
CC       decreased activity of the pyruvate dehydrogenase complex without
CC       observable reduction in the activities of enzymes E1, E2, or E3.
CC       Clinical features include hypotonia and psychomotor retardation.
CC       {ECO:0000269|PubMed:9399911}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the 2-oxoacid dehydrogenase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF001437; AAB66315.1; -; mRNA.
DR   EMBL; Y13145; CAA73606.1; -; mRNA.
DR   EMBL; U82328; AAC39661.1; -; mRNA.
DR   EMBL; AJ298105; CAC18649.1; -; Genomic_DNA.
DR   EMBL; AK301384; BAG62924.1; -; mRNA.
DR   EMBL; AC107928; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL138810; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68158.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68160.1; -; Genomic_DNA.
DR   EMBL; BC010389; AAH10389.1; -; mRNA.
DR   EMBL; U79296; AAB50223.1; -; mRNA.
DR   CCDS; CCDS44569.1; -. [O00330-3]
DR   CCDS; CCDS53616.1; -. [O00330-2]
DR   CCDS; CCDS7896.1; -. [O00330-1]
DR   RefSeq; NP_001128496.1; NM_001135024.1. [O00330-3]
DR   RefSeq; NP_001159630.1; NM_001166158.1. [O00330-2]
DR   RefSeq; NP_003468.2; NM_003477.2. [O00330-1]
DR   UniGene; Hs.502315; -.
DR   PDB; 1ZY8; X-ray; 2.59 A; K/L/M/N/O=54-274.
DR   PDB; 2DNC; NMR; -; A=57-141.
DR   PDB; 2F5Z; X-ray; 2.18 A; K/L/M/N/O=173-228.
DR   PDB; 2F60; X-ray; 1.55 A; K=173-228.
DR   PDBsum; 1ZY8; -.
DR   PDBsum; 2DNC; -.
DR   PDBsum; 2F5Z; -.
DR   PDBsum; 2F60; -.
DR   ProteinModelPortal; O00330; -.
DR   SMR; O00330; -.
DR   BioGrid; 113737; 31.
DR   DIP; DIP-29026N; -.
DR   IntAct; O00330; 11.
DR   MINT; MINT-1482590; -.
DR   STRING; 9606.ENSP00000227868; -.
DR   iPTMnet; O00330; -.
DR   PhosphoSitePlus; O00330; -.
DR   SwissPalm; O00330; -.
DR   BioMuta; PDHX; -.
DR   EPD; O00330; -.
DR   MaxQB; O00330; -.
DR   PaxDb; O00330; -.
DR   PeptideAtlas; O00330; -.
DR   PRIDE; O00330; -.
DR   DNASU; 8050; -.
DR   Ensembl; ENST00000227868; ENSP00000227868; ENSG00000110435. [O00330-1]
DR   Ensembl; ENST00000430469; ENSP00000415695; ENSG00000110435. [O00330-2]
DR   Ensembl; ENST00000448838; ENSP00000389404; ENSG00000110435. [O00330-3]
DR   GeneID; 8050; -.
DR   KEGG; hsa:8050; -.
DR   UCSC; uc001mvt.4; human. [O00330-1]
DR   CTD; 8050; -.
DR   DisGeNET; 8050; -.
DR   GeneCards; PDHX; -.
DR   HGNC; HGNC:21350; PDHX.
DR   HPA; HPA038484; -.
DR   HPA; HPA038485; -.
DR   MalaCards; PDHX; -.
DR   MIM; 245349; phenotype.
DR   MIM; 608769; gene.
DR   neXtProt; NX_O00330; -.
DR   OpenTargets; ENSG00000110435; -.
DR   Orphanet; 255182; Pyruvate dehydrogenase E3-binding protein deficiency.
DR   PharmGKB; PA134976445; -.
DR   eggNOG; KOG0557; Eukaryota.
DR   eggNOG; COG0508; LUCA.
DR   GeneTree; ENSGT00860000133743; -.
DR   HOGENOM; HOG000281566; -.
DR   HOVERGEN; HBG005063; -.
DR   InParanoid; O00330; -.
DR   KO; K13997; -.
DR   OMA; SWRLGCD; -.
DR   OrthoDB; EOG091G0CAV; -.
DR   PhylomeDB; O00330; -.
DR   TreeFam; TF332256; -.
DR   BioCyc; MetaCyc:ENSG00000110435-MONOMER; -.
DR   Reactome; R-HSA-204174; Regulation of pyruvate dehydrogenase (PDH) complex.
DR   Reactome; R-HSA-389661; Glyoxylate metabolism and glycine degradation.
DR   Reactome; R-HSA-5362517; Signaling by Retinoic Acid.
DR   Reactome; R-HSA-70268; Pyruvate metabolism.
DR   ChiTaRS; PDHX; human.
DR   EvolutionaryTrace; O00330; -.
DR   GeneWiki; E3_binding_protein; -.
DR   GenomeRNAi; 8050; -.
DR   PRO; PR:O00330; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000110435; -.
DR   CleanEx; HS_PDHX; -.
DR   CleanEx; HS_PDX1; -.
DR   ExpressionAtlas; O00330; baseline and differential.
DR   Genevisible; O00330; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0045254; C:pyruvate dehydrogenase complex; IDA:UniProtKB.
DR   GO; GO:0016746; F:transferase activity, transferring acyl groups; IEA:InterPro.
DR   GO; GO:0046487; P:glyoxylate metabolic process; TAS:Reactome.
DR   GO; GO:0061732; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; IC:MGI.
DR   GO; GO:0006090; P:pyruvate metabolic process; TAS:Reactome.
DR   GO; GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome.
DR   Gene3D; 4.10.320.10; -; 1.
DR   InterPro; IPR003016; 2-oxoA_DH_lipoyl-BS.
DR   InterPro; IPR001078; 2-oxoacid_DH_actylTfrase.
DR   InterPro; IPR000089; Biotin_lipoyl.
DR   InterPro; IPR004167; E3-bd.
DR   InterPro; IPR011053; Single_hybrid_motif.
DR   Pfam; PF00198; 2-oxoacid_dh; 1.
DR   Pfam; PF00364; Biotin_lipoyl; 1.
DR   Pfam; PF02817; E3_binding; 1.
DR   SUPFAM; SSF47005; SSF47005; 1.
DR   SUPFAM; SSF51230; SSF51230; 1.
DR   PROSITE; PS50968; BIOTINYL_LIPOYL; 1.
DR   PROSITE; PS00189; LIPOYL; 1.
DR   PROSITE; PS51826; PSBD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Lipoyl; Mitochondrion; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transit peptide.
FT   TRANSIT       1     53       Mitochondrion. {ECO:0000250}.
FT   CHAIN        54    501       Pyruvate dehydrogenase protein X
FT                                component, mitochondrial.
FT                                /FTId=PRO_0000020484.
FT   DOMAIN       56    132       Lipoyl-binding. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01066}.
FT   DOMAIN      183    220       Peripheral subunit-binding (PSBD).
FT                                {ECO:0000255|PROSITE-ProRule:PRU01170}.
FT   COMPBIAS    149    170       Pro-rich.
FT   MOD_RES      97     97       N6-lipoyllysine. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01066,
FT                                ECO:0000269|PubMed:25525879}.
FT   MOD_RES     194    194       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     196    196       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     394    394       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BKZ9}.
FT   VAR_SEQ       2     53       AASWRLGCDPRLLRYLVGFPGRRSVGLVKGALGWSVSRGAN
FT                                WRWFHSTQWLR -> QSGGAEGSPGAGRTGRGPGSGKAPPA
FT                                EISSGAPDFPG (in isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_053817.
FT   VAR_SEQ     115    341       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_045271.
FT   VARIANT      23     23       R -> C (in dbSNP:rs1049306).
FT                                {ECO:0000269|PubMed:9242632}.
FT                                /FTId=VAR_046619.
FT   VARIANT     101    101       T -> A (in dbSNP:rs11539202).
FT                                /FTId=VAR_046620.
FT   VARIANT     370    370       D -> V (in dbSNP:rs17850649).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_046621.
FT   MUTAGEN     183    183       R->A: Strongly decreased DLD binding.
FT                                {ECO:0000269|PubMed:16442803}.
FT   MUTAGEN     185    185       S->A: Strongly decreased DLD binding.
FT                                {ECO:0000269|PubMed:16442803}.
FT   MUTAGEN     186    186       P->A: Strongly decreased DLD binding.
FT                                {ECO:0000269|PubMed:16442803}.
FT   MUTAGEN     187    187       A->M: Strongly decreased DLD binding.
FT                                {ECO:0000269|PubMed:16442803}.
FT   MUTAGEN     189    189       R->A: Strongly decreased DLD binding.
FT                                {ECO:0000269|PubMed:16442803}.
FT   MUTAGEN     190    190       N->A: Decreased DLD binding.
FT                                {ECO:0000269|PubMed:16442803,
FT                                ECO:0000269|PubMed:20160912}.
FT   MUTAGEN     190    190       N->K: Moderately decreased interaction
FT                                with DLD. {ECO:0000269|PubMed:20160912}.
FT   MUTAGEN     193    193       E->A: Strongly decreased DLD binding.
FT                                {ECO:0000269|PubMed:16442803}.
FT   MUTAGEN     208    208       R->A: Strongly decreased DLD binding.
FT                                {ECO:0000269|PubMed:16442803}.
FT   MUTAGEN     208    208       R->D: Decreased interaction with DLD.
FT                                {ECO:0000269|PubMed:20160912}.
FT   MUTAGEN     210    210       I->A: Strongly decreased DLD binding.
FT                                {ECO:0000269|PubMed:16442803}.
FT   MUTAGEN     210    210       I->R: Decreased interaction with DLD.
FT                                {ECO:0000269|PubMed:20160912}.
FT   MUTAGEN     210    210       I->S: Decreased interaction with DLD.
FT                                {ECO:0000269|PubMed:20160912}.
FT   MUTAGEN     213    213       K->A: Strongly decreased DLD binding.
FT                                {ECO:0000269|PubMed:16442803}.
FT   MUTAGEN     214    214       E->A: Strongly decreased DLD binding.
FT                                {ECO:0000269|PubMed:16442803}.
FT   CONFLICT     41     41       A -> R (in Ref. 3; AAC39661).
FT                                {ECO:0000305}.
FT   CONFLICT    251    251       A -> S (in Ref. 1; AAB66315 and 2;
FT                                CAA73606). {ECO:0000305}.
FT   CONFLICT    344    344       P -> S (in Ref. 5; BAG62924).
FT                                {ECO:0000305}.
FT   STRAND       57     60       {ECO:0000244|PDB:2DNC}.
FT   STRAND       69     71       {ECO:0000244|PDB:2DNC}.
FT   STRAND       73     78       {ECO:0000244|PDB:2DNC}.
FT   STRAND       88     94       {ECO:0000244|PDB:2DNC}.
FT   STRAND       99    103       {ECO:0000244|PDB:2DNC}.
FT   STRAND      108    112       {ECO:0000244|PDB:2DNC}.
FT   STRAND      122    125       {ECO:0000244|PDB:2DNC}.
FT   STRAND      127    132       {ECO:0000244|PDB:2DNC}.
FT   HELIX       180    183       {ECO:0000244|PDB:2F60}.
FT   HELIX       186    194       {ECO:0000244|PDB:2F60}.
FT   HELIX       199    201       {ECO:0000244|PDB:2F60}.
FT   HELIX       207    209       {ECO:0000244|PDB:2F60}.
FT   HELIX       213    228       {ECO:0000244|PDB:2F60}.
SQ   SEQUENCE   501 AA;  54122 MW;  9CF0C1DAE9E12EF9 CRC64;
     MAASWRLGCD PRLLRYLVGF PGRRSVGLVK GALGWSVSRG ANWRWFHSTQ WLRGDPIKIL
     MPSLSPTMEE GNIVKWLKKE GEAVSAGDAL CEIETDKAVV TLDASDDGIL AKIVVEEGSK
     NIRLGSLIGL IVEEGEDWKH VEIPKDVGPP PPVSKPSEPR PSPEPQISIP VKKEHIPGTL
     RFRLSPAARN ILEKHSLDAS QGTATGPRGI FTKEDALKLV QLKQTGKITE SRPTPAPTAT
     PTAPSPLQAT AGPSYPRPVI PPVSTPGQPN AVGTFTEIPA SNIRRVIAKR LTESKSTVPH
     AYATADCDLG AVLKVRQDLV KDDIKVSVND FIIKAAAVTL KQMPDVNVSW DGEGPKQLPF
     IDISVAVATD KGLLTPIIKD AAAKGIQEIA DSVKALSKKA RDGKLLPEEY QGGSFSISNL
     GMFGIDEFTA VINPPQACIL AVGRFRPVLK LTEDEEGNAK LQQRQLITVT MSSDSRVVDD
     ELATRFLKSF KANLENPIRL A
//
